CARM
CARISMA THERAPEUTICS INCstockOTC
eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company's unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.00 | 2026-11-12 | -50.00% | -31.208 |
| 3M | 0.00 | 2026-08-19 | -90.91% | -70.544 |
| 6M | 0.00 | 2026-05-19 | +100.00% | -273.304 |
| 1Y | 0.05 | 2025-11-19 | -99.61% | -161.802 |
| 2Y | 0.87 | 2024-11-19 | -99.98% | — |
| 5Y | 3.61 | 2023-03-09 | -99.99% | -36.786 |
CARISMA THERAPEUTICS INC (OTC:CARM) stock price today is $0.00, and today's volume is 1,821. CARM is down 33.333% today. The 30 day average volume is 56,245. CARM market cap is $8,358 with 41.79M shares outstanding.